Prot #M24-427: A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

Project: Research project

Project Details

StatusActive
Effective start/end date3/13/24 → 3/13/27

Funding

  • Parexel (Prot #M24-427 // Prot #M24-427)
  • AbbVie Inc. (Prot #M24-427 // Prot #M24-427)